Re: "Naratriptan in the prophylaxis of transformed migraine" (Sheftell FD Rapoport AM, Coddon DR. Headache.1999,39:506-510).
作者信息
Warner J S
出版信息
Headache. 2000 Mar;40(3):252. doi: 10.1046/j.1526-4610.2000.00037.x.
Abstract
摘要
相似文献
1
Re: "Naratriptan in the prophylaxis of transformed migraine" (Sheftell FD Rapoport AM, Coddon DR. Headache.1999,39:506-510).
Headache. 2000 Mar;40(3):252. doi: 10.1046/j.1526-4610.2000.00037.x.
2
Naratriptan prophylaxis of transformed migraine or hemicrania continua?
Headache. 2000 Jun;40(6):498-9. doi: 10.1046/j.1526-4610.2000.00078.x.
3
Looking forward: the expanding utility of sumatriptan and naratriptan.
Cephalalgia. 2001;21 Suppl 1:35-8. doi: 10.1046/0333102401021s0112.
4
Building on the sumatriptan experience: the development of naratriptan.
Cephalalgia. 2001;21 Suppl 1:32-4. doi: 10.1046/0333102401021s0111.
5
Worsening of transformed migraine with naratriptan as prophylactic treatment.
Headache. 2000 Jul-Aug;40(7):610-1. doi: 10.1046/j.1526-4610.2000.00096-4.x.
6
Comparison of naratriptan and sumatriptan in recurrence-prone migraine patients. Naratriptan International Recurrence Study Group.
Clin Ther. 2000 Aug;22(8):981-9. doi: 10.1016/s0149-2918(00)80069-7.
7
Vasoconstrictive properties of the 5HT1B/1D agonists: response to Dahlöf and Mathew.
Cephalalgia. 1999 Jun;19(5):536-7. doi: 10.1177/033310249901900503.
8
Naratriptan: an alternative for migraine.
Ann Pharmacother. 1999 Jun;33(6):704-11. doi: 10.1345/aph.18300.
9
Efficacy of naratriptan tablets in the acute treatment of migraine: a dose-ranging study. Naratriptan S2WB2004 Study Group.
Clin Ther. 2000 Aug;22(8):970-80. doi: 10.1016/s0149-2918(00)80068-5.
10
Headache after frequent use of serotonin agonists zolmitriptan and naratriptan.
Lancet. 1999 Jan 30;353(9150):378. doi: 10.1016/S0140-6736(05)74950-3.
Zotero 插件